CHINA EB LTD (00165) released its interim results, reporting a loss attributable to shareholders of HKD 2.06 billion, a year-on-year turnaround from profit to loss, with an interim dividend of HKD 0.04.

date
20:25 27/08/2026
avatar
GMT Eight
China Everbright Holdings (00165) announced its interim results for the six months ending June 30, 2026, with a revenue of HK$4.489 billion, representing a year-on-year increase of 60.26%; a loss attributable to shareholders of HK$2.06 billion, turning from profit to loss compared to the same period last year; a loss per share of HK$1.222; and an interim dividend of HK$0.04 per share.
CHINA EB LTD (00165) announced its interim results for the six months ending June 30, 2026, reporting a total revenue of HKD 4.489 billion, a year-on-year increase of 60.26%; a loss attributable to shareholders of HKD 2.06 billion, a turnaround from profit to loss; a loss per share of HKD 1.222; and an interim dividend of HKD 0.04 per share. In terms of fund management business, as of June 30, 2026, the total assets under management (AUM) by China Everbright Holdings amounted to approximately HKD 121.8 billion, with 66 funds covering a diverse range of asset management products, including primary market funds, secondary market funds, mother funds, and S funds. They have cultivated numerous enterprises with high growth potential in collaboration with investors. China Everbright Holdings fully leverages its cross-border investment platform, delving into sectors such as technological innovation, emerging pillar industries, and future industries, nurturing new productive forces and aiding the development of the real economy. Regarding the proprietary capital investment business, as of June 30, 2026, the scale of proprietary capital investments by China Everbright Holdings was approximately HKD 33.4 billion. Among these, the company holds partial equity interests in CEB BANK Co., Ltd. ("China Everbright Bank") and EB SECURITIES Co., Ltd. ("EB SECURITIES") as cornerstone investments. At the same time, the company adheres to the principles of patient capital investment and long-termism, constructing a diversified investment layout through financial investment portfolios, including (i) direct equity investments that closely align with national strategies and policy orientations, focusing on key field projects to achieve growth returns; (ii) fund investments that seize advantageous fund investment opportunities, linking quality industry resources and deepening internal and external ecological cooperation; (iii) long-term equity investments that persist in value incubation and deep empowerment, nurturing quality enterprises with strategic and social value.